United States Anti-Glaucoma Ophthalmic Drug Market Report 2016

November 2016 | 101 pages | ID: U58F6A37BAAEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Anti-Glaucoma Ophthalmic Drug

Revenue, means the sales value of Anti-Glaucoma Ophthalmic Drug

This report studies sales (consumption) of Anti-Glaucoma Ophthalmic Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Bayer HealthCare Pharmaceuticals (Germany)
• Pfizer Incorporated (USA)
• GlaxoSmithKline Plc (UK)
• Merck & Company Incorporated (USA)
• Syneron Medical Ltd. (Israel)
• Valeant Pharmaceuticals International (USA)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Anti-Glaucoma Ophthalmic Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Anti-Glaucoma Ophthalmic Drug Market Report 2016

1 ANTI-GLAUCOMA OPHTHALMIC DRUG OVERVIEW

1.1 Product Overview and Scope of Anti-Glaucoma Ophthalmic Drug
1.2 Classification of Anti-Glaucoma Ophthalmic Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Anti-Glaucoma Ophthalmic Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Anti-Glaucoma Ophthalmic Drug (2011-2021)
  1.4.1 United States Anti-Glaucoma Ophthalmic Drug Sales and Growth Rate (2011-2021)
  1.4.2 United States Anti-Glaucoma Ophthalmic Drug Revenue and Growth Rate (2011-2021)

2 UNITED STATES ANTI-GLAUCOMA OPHTHALMIC DRUG COMPETITION BY MANUFACTURERS

2.1 United States Anti-Glaucoma Ophthalmic Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Anti-Glaucoma Ophthalmic Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Anti-Glaucoma Ophthalmic Drug Average Price by Manufactures (2015 and 2016)
2.4 Anti-Glaucoma Ophthalmic Drug Market Competitive Situation and Trends
  2.4.1 Anti-Glaucoma Ophthalmic Drug Market Concentration Rate
  2.4.2 Anti-Glaucoma Ophthalmic Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANTI-GLAUCOMA OPHTHALMIC DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Anti-Glaucoma Ophthalmic Drug Sales and Market Share by Type (2011-2016)
3.2 United States Anti-Glaucoma Ophthalmic Drug Revenue and Market Share by Type (2011-2016)
3.3 United States Anti-Glaucoma Ophthalmic Drug Price by Type (2011-2016)
3.4 United States Anti-Glaucoma Ophthalmic Drug Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ANTI-GLAUCOMA OPHTHALMIC DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Anti-Glaucoma Ophthalmic Drug Sales and Market Share by Application (2011-2016)
4.2 United States Anti-Glaucoma Ophthalmic Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ANTI-GLAUCOMA OPHTHALMIC DRUG MANUFACTURERS PROFILES/ANALYSIS

5.1 Bayer HealthCare Pharmaceuticals (Germany)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Anti-Glaucoma Ophthalmic Drug Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Bayer HealthCare Pharmaceuticals (Germany) Anti-Glaucoma Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Pfizer Incorporated (USA)
  5.2.2 Anti-Glaucoma Ophthalmic Drug Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Pfizer Incorporated (USA) Anti-Glaucoma Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc (UK)
  5.3.2 Anti-Glaucoma Ophthalmic Drug Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc (UK) Anti-Glaucoma Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Merck & Company Incorporated (USA)
  5.4.2 Anti-Glaucoma Ophthalmic Drug Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Merck & Company Incorporated (USA) Anti-Glaucoma Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Syneron Medical Ltd. (Israel)
  5.5.2 Anti-Glaucoma Ophthalmic Drug Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Syneron Medical Ltd. (Israel) Anti-Glaucoma Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Valeant Pharmaceuticals International (USA)
  5.6.2 Anti-Glaucoma Ophthalmic Drug Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Valeant Pharmaceuticals International (USA) Anti-Glaucoma Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview

6 ANTI-GLAUCOMA OPHTHALMIC DRUG MANUFACTURING COST ANALYSIS

6.1 Anti-Glaucoma Ophthalmic Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Anti-Glaucoma Ophthalmic Drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Anti-Glaucoma Ophthalmic Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Anti-Glaucoma Ophthalmic Drug Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ANTI-GLAUCOMA OPHTHALMIC DRUG MARKET FORECAST (2016-2021)

10.1 United States Anti-Glaucoma Ophthalmic Drug Sales, Revenue Forecast (2016-2021)
10.2 United States Anti-Glaucoma Ophthalmic Drug Sales Forecast by Type (2016-2021)
10.3 United States Anti-Glaucoma Ophthalmic Drug Sales Forecast by Application (2016-2021)
10.4 Anti-Glaucoma Ophthalmic Drug Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti-Glaucoma Ophthalmic Drug
Table Classification of Anti-Glaucoma Ophthalmic Drug
Figure United States Sales Market Share of Anti-Glaucoma Ophthalmic Drug by Type in 2015
Table Application of Anti-Glaucoma Ophthalmic Drug
Figure United States Sales Market Share of Anti-Glaucoma Ophthalmic Drug by Application in 2015
Figure United States Anti-Glaucoma Ophthalmic Drug Sales and Growth Rate (2011-2021)
Figure United States Anti-Glaucoma Ophthalmic Drug Revenue and Growth Rate (2011-2021)
Table United States Anti-Glaucoma Ophthalmic Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Anti-Glaucoma Ophthalmic Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anti-Glaucoma Ophthalmic Drug Sales Share by Manufacturers
Figure 2016 Anti-Glaucoma Ophthalmic Drug Sales Share by Manufacturers
Table United States Anti-Glaucoma Ophthalmic Drug Revenue by Manufacturers (2015 and 2016)
Table United States Anti-Glaucoma Ophthalmic Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Anti-Glaucoma Ophthalmic Drug Revenue Share by Manufacturers
Table 2016 United States Anti-Glaucoma Ophthalmic Drug Revenue Share by Manufacturers
Table United States Market Anti-Glaucoma Ophthalmic Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Anti-Glaucoma Ophthalmic Drug Average Price of Key Manufacturers in 2015
Figure Anti-Glaucoma Ophthalmic Drug Market Share of Top 3 Manufacturers
Figure Anti-Glaucoma Ophthalmic Drug Market Share of Top 5 Manufacturers
Table United States Anti-Glaucoma Ophthalmic Drug Sales by Type (2011-2016)
Table United States Anti-Glaucoma Ophthalmic Drug Sales Share by Type (2011-2016)
Figure United States Anti-Glaucoma Ophthalmic Drug Sales Market Share by Type in 2015
Table United States Anti-Glaucoma Ophthalmic Drug Revenue and Market Share by Type (2011-2016)
Table United States Anti-Glaucoma Ophthalmic Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Anti-Glaucoma Ophthalmic Drug by Type (2011-2016)
Table United States Anti-Glaucoma Ophthalmic Drug Price by Type (2011-2016)
Figure United States Anti-Glaucoma Ophthalmic Drug Sales Growth Rate by Type (2011-2016)
Table United States Anti-Glaucoma Ophthalmic Drug Sales by Application (2011-2016)
Table United States Anti-Glaucoma Ophthalmic Drug Sales Market Share by Application (2011-2016)
Figure United States Anti-Glaucoma Ophthalmic Drug Sales Market Share by Application in 2015
Table United States Anti-Glaucoma Ophthalmic Drug Sales Growth Rate by Application (2011-2016)
Figure United States Anti-Glaucoma Ophthalmic Drug Sales Growth Rate by Application (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List
Table Bayer HealthCare Pharmaceuticals (Germany) Anti-Glaucoma Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare Pharmaceuticals (Germany) Anti-Glaucoma Ophthalmic Drug Sales Market Share (2011-2016)
Table Pfizer Incorporated (USA) Basic Information List
Table Pfizer Incorporated (USA) Anti-Glaucoma Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Incorporated (USA) Anti-Glaucoma Ophthalmic Drug Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Anti-Glaucoma Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Anti-Glaucoma Ophthalmic Drug Sales Market Share (2011-2016)
Table Merck & Company Incorporated (USA) Basic Information List
Table Merck & Company Incorporated (USA) Anti-Glaucoma Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Company Incorporated (USA) Anti-Glaucoma Ophthalmic Drug Sales Market Share (2011-2016)
Table Syneron Medical Ltd. (Israel) Basic Information List
Table Syneron Medical Ltd. (Israel) Anti-Glaucoma Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Syneron Medical Ltd. (Israel) Anti-Glaucoma Ophthalmic Drug Sales Market Share (2011-2016)
Table Valeant Pharmaceuticals International (USA) Basic Information List
Table Valeant Pharmaceuticals International (USA) Anti-Glaucoma Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Pharmaceuticals International (USA) Anti-Glaucoma Ophthalmic Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Glaucoma Ophthalmic Drug
Figure Manufacturing Process Analysis of Anti-Glaucoma Ophthalmic Drug
Figure Anti-Glaucoma Ophthalmic Drug Industrial Chain Analysis
Table Raw Materials Sources of Anti-Glaucoma Ophthalmic Drug Major Manufacturers in 2015
Table Major Buyers of Anti-Glaucoma Ophthalmic Drug
Table Distributors/Traders List
Figure United States Anti-Glaucoma Ophthalmic Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Anti-Glaucoma Ophthalmic Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Anti-Glaucoma Ophthalmic Drug Production Forecast by Type (2016-2021)
Table United States Anti-Glaucoma Ophthalmic Drug Consumption Forecast by Application (2016-2021)